The scoop: Marathon’s R&D program for Duchenne MD drug likely came in at a bargain basement price
On Friday, as news spread about the FDA’s approval of Marathon …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
